Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Albireo Pharma
Albireo Pharma
(ALBO)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Bylvay
Odevixibat
2021-07-16
2031-2041
Pruritus
,
Intrahepatic cholestasis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Odevixibat
liver diseases
,
healthy volunteers/patients
,
biliary liver cirrhosis
,
liver cirrhosis
,
fibrosis
,
pruritus
,
cholestasis
,
alagille syndrome
,
intrahepatic cholestasis
,
syndrome
,
biliary atresia
,
pregnancy rate
Elobixibat
non-alcoholic fatty liver disease
,
dyslipidemias
,
constipation
Insulin
rheumatoid arthritis
,
arthritis
,
neoplasms
,
hyperkalemia
,
hypertension
,
type 1 diabetes mellitus
,
hypoglycemia
,
obesity
,
diabetic retinopathy
,
heart failure
,
weight gain
,
polycystic ovary syndrome
,
type 2 diabetes mellitus
,
diabetes mellitus
,
insulin resistance
,
hyperglycemia
,
cardiovascular diseases
,
hypersensitivity
,
breast neoplasms
,
urinary bladder neoplasms
,
pancreatitis
,
healthy volunteers/patients
,
congenital abnormalities
,
premature birth
,
gestational diabetes
,
pregnancy in diabetics
,
pancreatic neoplasms
Viaject
lung neoplasms
,
obesity
,
non-small-cell lung carcinoma
,
asthma
,
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
,
carcinoma
,
squamous cell carcinoma
,
squamous cell neoplasms
,
adenosquamous carcinoma
,
large cell carcinoma
,
atherosclerosis
,
vascular diseases
,
diabetes mellitus
,
type 2 diabetes mellitus
,
type 1 diabetes mellitus
,
insulin resistance
,
schizophrenia
,
metabolic syndrome
,
stroke
,
coronary artery bypass
,
unstable angina
,
myocardial revascularization
,
syndrome
,
acromegaly
,
prediabetic state
,
hypersensitivity
,
glucose intolerance
,
fatty liver
,
metabolism
,
pituitary dwarfism
,
dwarfism
,
diabetic angiopathies
,
diabetic nephropathies
,
kidney diseases
,
diabetes complications
,
retinal diseases
,
diabetic neuropathies
,
diabetic retinopathy
,
psychotic disorders
,
bipolar disorder
,
hyperlipidemias
,
hyperglycemia
Isoxaflutole
sialorrhea
,
neurodevelopmental disorders
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use